Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Plasma cell 1Dermatologic 1

Conditions

Multiple Myeloma 2Waldenstrom Macroglobulinemia 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

fludarabine phosphate 23Peripheral Blood Stem Cell Transplantation 21Whole-Body Irradiation 17Mycophenolic Acid 16Cyclophosphamide 15Cyclosporine 14Tacrolimus 11Antilymphocyte Serum 10Busulfan 9Methotrexate 7Melphalan 7Therapeutics 4Sirolimus 4Methylprednisolone 4Etoposide 4Transplantation 3Filgrastim 3Epoetin Alfa 3Darbepoetin alfa 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2sargramostim 2merphos 2liposomal amphotericin B 2Rituximab 2Radiotherapy 2Polymerase Chain Reaction 2Pharmacogenomic Testing 2Pentetic Acid 2Panobinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × MLN 8237 × Plasma cell × Clear all
NCT00697346 2019-05-31

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Takeda

Phase 1 Completed
58 enrolled 52 charts
LymphoidOther hematologic neoplasmPlasma cell

Immunoblastic Lymphadenopathy, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡